PropertyValue
?:abstract
  • Most patients with overt hepatic encephalopathy are managed in an acute hospital setting. The mainstays of treatment are non-absorbable disaccharides, To prevent a recurrence, and thus further hospital admission, the focus is on identifying and avoiding precipitants, optimising nutrition and prescribing medication including rifaximin-α*†.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.12968/bjon.2020.29.sup17.s14
?:journal
  • British_journal_of_nursing
?:license
  • unk
?:pmid
?:pmid
  • 32976024.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Overt hepatic encephalopathy: management and prevention of recurrence.
?:type
?:year
  • 2020-09-01

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/b3ar6hj9>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/b3ar6hj9>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all